KBC Securities - AZELIS GROUP NV (AZE) AZELIS: A formula for success, with a price to pay AZE BB

Report

KBC Securities

Thibault Leneeuw

AZELIS: A formula for success, with a price to pay AZE BB

Initiation of coverage
This note dives into the specialty chemical distribution market as we launch our coverage of Azelis. We will look at the company’s activities and how it grew to be what it is today. We’ll consider the market, the competition and the business model from which we derived our valuation. We’ll also offer additional ESG information.

25/05/2022 1 EN

Underlying

AZELIS GROUP NV

See profile

BE0974400328 Euronext Brussels Belgium

Provider

KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

See profile

Analysts

Thibault Leneeuw

Other Reports on these Companies

KBC Securities

Dynamic Top Pick List Update October: Removing VGP – Adding Shurgard and Wolters Kluwer

In this October update of our Dynamic Top Pick List we are removing VGP while adding Shurgard and Wolters Kluwer. Since its recent inclusion in our Dynamic Top Pick List in July-25, VGPs share rose by 10.6%. While we still believe there is significant upside to the share price, we don't see short term catalysts. In fact, the macro picture remains cloudy with the jury still out on the impact of tariffs and the erratic US policy shifts. Also, we are a bit concerned that competition in Western Europe increases after we attended the CTP capital markets day. We decided to add Shurgard to the Dyna...

October 2, 2025 October 2, 2025 1 EN

ING Financial Markets

Benelux Morning Notes

ASML: Chinese advanced DUV machine on trial; Azelis: Muddling through 2025 PostNL: CMD - new strategy and ambitions for 2028; Proximus: New CEO of Proximus Global announced Syensqo: CEO succession; UCB: Brivekimig (Sanofi) P2a results in Hidradenitis Suppurativa

September 17, 2025 September 17, 2025 1 EN

ING Financial Markets

Benelux Morning Notes

Azelis: Highlights ING Benelux Conference London. Barco: Highlights ING Benelux Conference London. Kinepolis: Highlights ING Benelux Conference London. Melexis: Highlights ING Benelux Conference London. ABN AMRO: Dutch State reducing stake to 20%. ASML: x Mistral, a bet on A.I.. Kinepolis: Cineplex August 2025 box office revenue at 87% of 2019 level, down 27% YoY

September 9, 2025 September 9, 2025 1 EN

Morning Notes : ASM NA, UCB BB, SHUR BB

: ASM NA, UCB BB, SHUR BB

5h / 9m 5h / 9m 1 EN

Jacob Mekhael

Jacob Mekhael

UCB Publishes Fintepla LGS open-label extension results in journal

UCB announced that the final analysis of an open-label extension (OLE) study on Fintepla (fenfluramine) in Lennox-Gastaut syndrome (LGS) was published in the Epilepsy and Behavior journal. This follows previous presentations at a medical conference and highlights the long-term sustained benefit and lack of new or unexpected safety signals, which we view as supportive of Fintepla's benefit in this patient population. For reference, Fintepla is one of UCB's 5 growth drivers, and we estimate peak sales of € 1.2bn. ACCUMULATE maintained.

5h / 25m 5h / 25m 1 EN

Wim Lewi

Wim Lewi

Shurgard Big Yellow speculation also shines on Shurgard

Blackstone has confirmed it's considering a cash bid for Big Yellow Group, the UK's leading self-storage operator. Big Yellow separately confirmed that it has held meetings with a "small number" of parties, but added that it has not received a formal bid. Shares in Big Yellow surged >20% on the news, reflecting investor optimism around consolidation in the sector. We believe the impact on Shurgard in the UK is positive. It highlights that private equity investors find the valuation attractive. Big Yellow was trading at a 26% discount to NTA before the speculation broke. We do not believe that ...

5h / 42m 5h / 42m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

AZELIS: A formula for success, with a price to pay AZE BB

We are a financial services provider for several types of professional clients, each with distinct needs.

Dynamic Top Pick List Update October: Removing VGP – Adding Shurgard and Wolters Kluwer

Benelux Morning Notes

Benelux Morning Notes

Morning Notes : ASM NA, UCB BB, SHUR BB

UCB Publishes Fintepla LGS open-label extension results in journal

Shurgard Big Yellow speculation also shines on Shurgard

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe